Yttrium (90Y) clivatuzumab tetraxetan is a radiolabeled monoclonal antibody that is used in targeted radiation therapy, specifically for the treatment of certain types of cancer. Here's a breakdown of its components: 1. **Yttrium-90 (90Y)**: This is a radioactive isotope of yttrium. It emits beta radiation, which can be used to destroy cancer cells in targeted therapy.
Articles by others on the same topic
There are currently no matching articles.